Oxford Nanopore Technologies said recently it has raised a total of ¡ê109.5 million ($144.4 million) between new capital investments and the sale of secondary shares.
The privately held, UK-based firm said it raised ¡ê29.3 million in capital and sold ¡ê80.2 million in shares. The investors include both new and existing shareholders from the US, Europe, and Asia/Pacific regions, the firm said in a statement.
Other details, including how the firm plans to use the proceeds, were not disclosed.
Oxford Nanopore said it has raised approximately ¡ê480 million to date. In October 2018, the firm announced that Amgen would take a ¡ê50 million stake, or approximately 3 percent of the firm at the time, giving it a ¡ê1.5 billion valuation.
In July 2019, Oxford Nanopore announced 2018 revenues of $43.7 million, up from $17.8 million in 2017.
In a tweet following the announcement, Oxford Nanopore CTO Clive Brown suggested that the minimum amount needed to invest in the firm is $20 million.
